For: | Lu QP, Cao TJ, Zhang ZY, Liu W. Multiple gene differential expression patterns in human ischemic liver: Safe limit of warm ischemic time. World J Gastroenterol 2004; 10(14): 2130-2133 [PMID: 15237451 DOI: 10.3748/wjg.v10.i14.2130] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i14/2130.htm |
Number | Citing Articles |
1 |
Scott W. Biggins, Kiran Bambha, Norah Terrault, John Inadomi, John P. Roberts, Nathan Bass. Transplant tourism to China: the impact on domestic patient‐care decisions. Clinical Transplantation 2009; 23(6): 831 doi: 10.1111/j.1399-0012.2008.00949.x
|
2 |
Seiji Fukuda, Louis M. Pelus. Survivin, a cancer target with an emerging role in normal adult tissues. Molecular Cancer Therapeutics 2006; 5(5): 1087 doi: 10.1158/1535-7163.MCT-05-0375
|
3 |
Laszlo Kunos, Peter Horvath, Adrian Kis, David Laszlo Tarnoki, Adam Domonkos Tarnoki, Zsofia Lazar, Andras Bikov. Circulating Survivin Levels in Obstructive Sleep Apnoea. Lung 2018; 196(4): 417 doi: 10.1007/s00408-018-0120-z
|
4 |
Gina Sánchez, Stefanie Chalmers, Xavier Ahumada, Luis Montecinos, Ivonne Olmedo, Veronica Eisner, Ana Riveros, Marcelo J. Kogan, Sergio Lavandero, Zully Pedrozo, Paulina Donoso, Edward J. Lesnefsky. Inhibition of chymotrypsin-like activity of the proteasome by ixazomib prevents mitochondrial dysfunction during myocardial ischemia. PLOS ONE 2020; 15(5): e0233591 doi: 10.1371/journal.pone.0233591
|
5 |
Fengzhi Li, Michael G. Brattain. Role of the SurvivinGene in Pathophysiology. The American Journal of Pathology 2006; 169(1): 1 doi: 10.2353/ajpath.2006.060121
|
6 |
Yana V. Syagailo, Wlad Kusnezow, Jörg D. Hoheisel. Apoptosis and Cancer Therapy. 2006; : 728 doi: 10.1002/9783527619665.ch28
|
7 |
Vesna Zderic, Grant E. O’Keefe, Jessica L. Foley, Shahram Vaezy. Resection of Abdominal Solid Organs Using High-Intensity Focused Ultrasound. Ultrasound in Medicine & Biology 2007; 33(8): 1251 doi: 10.1016/j.ultrasmedbio.2007.02.010
|
8 |
Adel Kardosh, Nathaniel Soriano, Peter Pyrko, Yen-Ting Liu, Mark Jabbour, Florence M. Hofman, Axel H. Schönthal. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib. Journal of Biomedical Science 2007; 14(5): 647 doi: 10.1007/s11373-007-9173-3
|
9 |
Matthias Bache, Daniel Holzapfel, Matthias Kappler, Hans-Jürgen Holzhausen, Helge Taubert, Jürgen Dunst, Gabriele Hänsgen. Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. Gynecologic Oncology 2007; 104(1): 139 doi: 10.1016/j.ygyno.2006.07.011
|
10 |
Karol L. Thompson, Joseph Hackett. Essential Concepts in Toxicogenomics. Methods in Molecular Biology™ 2008; 460: 45 doi: 10.1007/978-1-60327-048-9_3
|
11 |
Qinhui Song, Xiaojin An, Dongmei Li, Neel R. Sodha, Munir Boodhwani, Ye Tian, Frank W. Sellke, Jian Li. Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells. Microvascular Research 2009; 78(3): 257 doi: 10.1016/j.mvr.2009.08.006
|